ABSTRACT
INTRODUCTION
In the last ten years, the focus of biological research has shifted from individual genes and proteins towards the study of entire biological systems. One of the most important research issues is * To whom correspondence should be addressed.
gene/protein and disease relationship analysis. Sequence variation plays the key role between gene and disease. Therefore, identifying sequence variation is one of the major approaches for characterizing gene-disease relationships (Erdogmus and Sezerman, 2007; Schenck, et al., 2012) , with many study results subsequently reported in scientific publications. As such, text-mining mutation related information from the literature has become an increasingly important task in many downstream bioinformatics applications, such as the curation of mutation related biological databases (Gyimesi, et al., 2012; Kuipers, et al., 2012) , the systematic study of biological effects of protein mutations (Izarzugaza, et al., 2012; Winnenburg, et al., 2009) , and the interpretation of individual genomes towards personalized medicine in pharmacogenomics research (Capriotti, et al., 2012) .
Despite some reported success in identifying specific mutation types or identifiers such as dbSNP RS numbers (Yu, et al., 2009 ), mutation identification from free text in general remains a challenge because most mutations are not described in accordance with standard nomenclature (less than 25% in our corpus) and only few are mentioned with standard database identifiers such as dbSNP RS numbers (less than 10% in our corpus). To the opposite, it is common to see the same mutation described in many different nonstandard ways in the literature, which makes it similar to the named entity recognition task in biomedicine Morgan, et al., 2008) In response, recently a number of automatic systems have been developed for extracting mutation mentions from the biomedical literature (Caporaso, et al., 2007; McDonald, et al., 2004) and some investigated further with respect to mutations' associations with genes (Horn, et al., 2004; Rebholz-Schuhmann, et al., 2004) , diseases (Doughty, et al., 2011; Furlong, et al., 2008; Yeniterzi and Sezerman, 2009 ) and other related information (Kanagasabai, et al., 2007; Naderi and Witte, 2012) . Despite different scopes, with regard to methods for mutation detection, most systems rely on manually derived regular expressions. For instance, for detecting protein point mutations (e.g. A42G) from text, Caporaso and col-2 leagues developed MutationFinder (Caporaso, et al., 2007) , which contains over 700 regular expression patterns and achieves stateof-the-art performance of 90% in F-measure. Compared to the overwhelmingly used rule-based systems, VTag (McDonald, et al., 2004) stands out with a machine-learning approach and reports an F-measure of 0.82 on their evaluation data. We refer readers to (Izarzugaza, et al., 2012) for a summary of previous implementations for mutation extraction. Following VTag and other previous studies on biomedical named entities (Doğan and Lu, 2012b; Hsu, et al., 2008; Leaman and Gonzalez, 2008) , we formulated the problem of named entity recognition as a sequence-labeling problem. Therefore, a conditional random field (CRF) model (Lafferty, et al., 2001 ) was naturally chosen as our learning algorithm. However, as detailed in our method description, we developed a new CRF model with 11 labels (as opposed to the traditional BIO model) as well as a set of novel features in this work. As shown in the Discussion Section, both designs helped improve extraction performance and made our method compare favorably to the state of the art.
In addition, our work is also unique in extracting mutations of many types that are not considered by previous methods. Existing methods such as MutationFinder either exclusively aim for extracting point mutations in proteins or are limited to a few mutation types such as substitution and deletion in both proteins and genes. To our best knowledge, this work is the first attempt to identify various mutation types according to a standard nomenclature endorsed by the Human Genomic Variation Society (HGVS) for the description of sequence variants (mutations).
Finally, similar to MutationFinder, along with a public tool for mutation extraction, we also contribute to the text-mining community a large corpus (500 PubMed abstracts) of manually annotated raw and normalized mutation mentions. A raw mutation extraction is normalized when individual mutation components are identified and standardized when applicable. For instance, "Arg987Ter" (PMID: 22188495) is normalized as "p|R|987|X" to denote the replacement of an arginine residue at position 573 by termination codon, where a single letter 'p' is added to indicate the mutation type, and the standard one-letter codes are used (with their respective positions in the normalized notation) to represent the wild-type and mutant residue. As noted above, our corpus covers many kinds of mutations not previously considered such as "p.Pro246HisfsX13" (PMID: 21738389) and "IVS3+1G/A" (PMID: 15111599).
METHODS
As shown in Figure 1 , our method first performs tokenization on the input text as pre-processing. Next, our method extracts mutation mentions from text using a CRF-based approach, followed by some post-processing steps. As illustrated in the figure, instead of extracting a mutation mention such as c.2708_2711delTTAG as a whole, our CRF module identifies each mutation component (e.g. 'del' as the mutation type) individually. Finally, we have implemented a post-processing module to handle some rare mutation formulas and nature language mentions that are not curated in our own corpus. We describe details of each step below.
Pre-processing: Tokenization
A tokenizer divides text input into a sequence of tokens, which generally correspond to "words." However, in order to capture individual components within a mutation mention, we performed tokenization on a finer level than traditional methods (Webster and Kit, 1992 ) that separate input text by space or punctuation. Specifically, special characters (e.g. "-","*","+"), numbers, lowercase letters and uppercase letters are divided as separate tokens. For instance, instead of regarding the mention "c.2708_2711delTTAG" in Figure 1 as one token, we split it into seven pieces as shown in the top row of Table 1 . Fig. 1 . The system overview that includes three major components: preprocessing (tokenization), mutation identification (CRF), and postprocessing (regular expression patterns).
Mutation identification: CRF module
As mentioned above, we regarded the mutation identification problem as a sequence-labeling task. In particular, each mutation component was considered as an individual label (see Table 1 ) such that every mutation mention becomes a sequence of labels. Accordingly, we adapted a probabilitybased sequence detection CRF model (Lafferty, et al., 2001) , which defines the conditional probability distribution PሺY|Xሻ of label sequence Y given observation sequence X.
where y ଵ , … , y ୬ is a label sequence from Y and x ଵ , … , x ୬ is a token sequence from X. ‫ܨ‬ሺX, Yሻ ൌ ∑ ∑ ω ୧ f ୧ ൫y ୨ , y ୨ିଵ , X൯
is a global feature vector for label sequence Y and observation sequence X, and ω ଵ , … , ω ୵ is a feature weight vector.
CRF is a log-linear model based on a set of the feature functions f ୧ ൫y ୨ , y ୨ିଵ , X൯. This function determines the pair of state and observation tokens to a binary value, and associates with the weight ω ୧ . The weight presents the importance of the tag and can be obtained from the training data by a limited-memory Broyden-Fletcher-Goldfarb-Shanno (L-BFGS) (Liu and Nocedal, 1989) method. This model can combine the effects of many meaningful features. We then followed Wallach (Wallach, 2004) to design the observation function DሺX, i, jሻ and feature function:
1 if the jth token in X match to feature i 0 otherwise
The observation function returns true, if the token in j position matches the criteria of feature i, and vice versa. For example, if the token at xj is "glycine," then the observation function for the Protein symbols feature would return true. Consider the following feature function:
The f ୧ ൫y ୨ , y ୨ିଵ , X൯ would return true if the two labels of previous y ୨ିଵ and current y ୨ positions belong to one of our designed labels. The CRF model is determined by the features f ୧ ൫y ୨ , y ୨ିଵ , X൯ and their corresponding weight ω ୧ .
In this work, the y ଵ , … , y ୬ indicate the label for the corresponding tokens. Unlike the traditional BIO labeling models which label each token as being the beginning of (B), the inside of (I) or entirely outside (O) of a span of interest, we designed 10 different labels (Table 2 ) for describing mutation elements (i.e. tokens within the mutation mentions) based on the HGVS nomenclature, and one additional label "O" for all tokens outside a mention (see Table 1 for an example). In this work, we used the CRF++ (http://crfpp.googlecode.com/svn/trun-k/doc/index.html#download) for the actual implementation. Table 2 . We defined 10 different labels for tokens within mutation mentions: Reference sequence (A); Mutation position (P); Mutation type (T); wild type (W); Mutant (M); Frame shift (F); Frame shift position (S); Duplication time (D); SNP (R); Other inside mutation tokens (I). Each mutation type has its own set of labels (e.g. substitution corresponds to 6 labels).
Mutation types
A P T W M F S D R I Substitution • • • • • • Deletion • • • • • Insertion • • • • • Insertion/Deletion • • • • • Duplication • • • • • • Frame shift • • • • • • • • RS number •
Features for CRF
We engineered six different types of features for this problem:
(1) Dictionary features. We followed the HGVS mutation nomenclature and developed 11 (7 for genomic and 4 for protein mutations) regular expressions patterns as shown in Table 3 . When there is a match, each token in the corresponding matched text will be assigned to one of the three values ('B/I/E') for that feature (B for the beginning token; E for the last token and I for any other tokens in between B and E). Any token that is not matched against these patterns will have the value of 'O' for this feature.
(2) General linguistic features. Sometimes, the mutation mentions may include brief nature language such as "G-->A at nucleotide position 2141." In order to capture such mutations, we included the original tokens (e.g., nucleotide) as well as stemmed tokens (e.g., nucleotide) as features using the Porter's stemmer.
(3) Character features. We noticed that many mutation mentions contain numbers and special characters (e.g., the greater sign ">" is often used to represent amino acid substitution). Therefore, for each token we calculated several statistics as its features, including its number of digitals, number of uppercase and lower letters, number of all characters, and presence or absence of mutation-specific characters (; , . -> + -_ / ?).
(4) Semantic features. We created several semantic classes for describing mutation-specific characteristics. Any upper case alphabetic character is replaced by 'A' and any lower case one is replaced by 'a'. Likewise any number (0-9) is replaced by '0'. Thus the token 'TTAG' generates the case pattern feature 'AAAA' and the token '2711' generates the pattern feature '0000'. Moreover, we also merged consecutive letters and numbers and generated additional single letter 'a' and number '0' features.
(6) Contextual features. We observed that the tokens in the mutation mention are highly correlated with each other. Take the letter "G" for example; only six possible suffixes ("lycine", "lutamic", "lutamine", "ln", "ly", and "lu") can be associated with it to be an amino acid. In order to take advantage of contextual information, for a given token we included the dictionary and linguistic features of 3 neighboring tokens from each side.
Post-Processing: regular expression rules
Despite our best efforts, the CRF model may still miss a few mentions. To minimize the number of false negatives within an article, we took the mentions extracted by the CRF module and translated them into regular expression patterns for finding additional mentions of similar kind in the same article. Two rules were applied to make the translated patterns more generalizable: a) all numerical digitals become "[0 ," we built more robust and general patterns. As a result, only a few regular expression patterns (less than 10) were needed. The inclusion of such patterns also complements our CRF-based approach in extracting those long natural-language mutation mentions in the paper.
Based on examination of our method development data, we also developed several additional rules for matching irregular and rare mention formats such as "glycine-594-valine" and "dup33bp". In addition, our postprocessing step also helps adjust text spans of mutation mentions such as adding a missing closing parenthesis p.(Asp569Valfs*93 → p.(Asp569Valfs*93) or separating two consecutive mutations by semicolon rs1573496;C>G"→ "rs1573496" and "C>G".
As a result of past research on this topic (Bonis, et al., 2006; Caporaso, et al., 2007; Furlong, et al., 2008; Naderi and Witte, 2012) , several mutation corpora are publicly available, but are either limited in size and/or scope (protein point mutation) or lack mention-level annotations. Hence, we decided to develop our own corpus in this work. We used PubMed to obtain a corpus of MEDLINE abstracts that contained a large number of mutation mentions. In order to construct a corpus containing numerous mentions of the types of mutations we were interested in, we included many facets in our query, which is composed of both MeSH (Medical Subject Heading) terms and other search field terms. To ensure we returned abstracts containing mentions of clinically relevant mutations, the MeSH 'Diseases Category' was an essential component. We chose the MeSH terms 'Mutation' and 'Polymorphism, Genetic' to obtain abstracts that had been indexed as pertaining to genomic variation.
The 'Title/Abstract' field was searched for terms identified to retrieve information pertaining to sequence type, mutation type, and mutation location (see query below). This strategy was chosen after reviewing example abstracts containing desired mutation mentions and attempting to retrieve abstracts with similar characteristics. Lastly, we included non-genetic facets that accounted for the other preferences we had for our potential corpus. These aspects included needing abstracts in English and specifically about humans. We also wanted to ensure that only results containing abstracts were retrieved and that we did not retrieve review articles because we preferred articles about novel mutations, since mutations are likely to be mentioned in formulaic fashion when they are first described. We submitted this query and obtained 5,116 abstracts from PubMed in June 2012. We randomly selected 500 abstracts among those published after 2001 for manual annotation using PubTator (Wei, et al., 2012a; Wei, et al., 2012b) , a Web-based annotation tool (see a tool screenshot in Figure 2 ). Our corpus was developed in stages by human annotators who have domain expertise as well as experience in NLP corpus development. In the first phase, three human annotators annotated 50 abstracts individually. They then compared their results and only obtained inter-annotator agreement (IAA) of 46%. Most of the annotation discrepancies were found to be due to boundary issues (text spans of mutation mentions are overlapping but not identical) and varying conceptions of how to annotate nature language mentions. After discussion, a set of annotation guidelines was drafted (available with tmVar software and corpus). In the second phase, two of the annotators finished another set of 50 abstracts, reaching 88% agreement this time. In the final round, one annotator continued and finished the remaining 400 abstracts.
Fig. 2.
A screenshot of our applied curation system.
Baseline approach and additional gold standard for evaluation
As shown in the Results Section below, we compared our method with MutationFinder. As pointed out by (Izarzugaza, et al., 2012) , MutationFinder is "very competitive for recall and precision when compared to other strategies" and over the years it has been widely adopted by many others for extracting protein point mutation (Gyimesi, et al., 2012; Schenck, et al., 2012; Witte and Baker, 2007) . In addition, along with its public software, MutationFinder has a large corpus where both raw mentions and normalized annotations are available, which allowed us to perform crosscomparisons of both methods on two different gold-standard datasets.
RESULTS

Gold-standard evaluation data
As mentioned, our mutation corpus contains 500 articles. As shown in Figure 3 , one mutation type (substitution) alone accounts for approximately 70% of total annotations. Hence, we further divided the annotations in this group into two subgroups (i.e. amino acid substitution vs. nucleic acid substitution). Despite the fact that substitution plays a dominant role, there are quite a few other types of sequence variations seen in our corpus including deletion, insertion, and others. In order to use it as the gold standard for the method development and evaluation purposes, we randomly divided the whole set into two subsets. Detailed statistics about our corpus is shown in Table  4 . Additionally, we also used the MutationFinder corpus in benchmarking. Those statistics are also shown in the table below. 
System Performance
Following (Caporaso, et al., 2007) , we computed precision, recall and F-measure on all mentions (including duplicates) as well as on normalized mentions, which emphasizes an evaluating system's ability of extracting different mutations. In all cases, our method was compared with MutationFinder. Tables 5 and 6 show results on both our and MutationFinder corpus respectively. Because MutationFinder was designed exclusively for detecting protein point mutation, we report its performance on all mutations as well as just protein point mutations when using our test corpus. As such, there are two rows of results in Table 5 for MutationFinder.
As can been seen in Tables 5 and 6 , our method tmVar achieved consistently higher F-measures than MutationFinder (p < 0.05; two-sided t-test) on two independent datasets. On the other hand, when benchmarked on our corpus, MutationFinder's results (in Table 5 ) dropped significantly from the performance on its own corpus (in Table 6 ), especially in recall, even though we limited our evaluation to its extraction scope (protein point mutation). Our analysis shows that slight drop in precision was mainly because its patterns incorrectly identified DNA substitutions that are protein substitution-like (e.g. C35322T in PMID: 21054465) in our corpus.
In terms of recall, most missed mentions are due to the lack of its patterns to recognize nonsense point mutations (e.g. V561X in PMID: 15749661), and point mutations preceded with a sequence type (e.g. p.A150P in 15880727). 
DISCUSSION
Evaluation of post-processing step
As stated earlier, for optimal performance the results of CRF were further supplemented by a set of manually derived rules for handling issues such as mention boundaries, rare form mentions, etc. As shown in table below, when the post-processing module was removed altogether, modest drop in overall performance was found due to the loss in recall. As can be seen in Table 7 , experimental results using all mentions vs. normalized mentions yields similar findings. Hence, in the following analysis, only results using all mentions are reported.
Performance comparison with different CRF labeling models
As mentioned above, unlike previous rule-based approaches (Caporaso, et al., 2007; Doughty, et al., 2011; Furlong, et al., 2008) we developed a CRF-based method for extracting different elements of a mutation. Furthermore, different from the common labeling models such as B(beginning), I(inside), O(outside) or B(beginning), I(inside), E(end), O(outside) (Settles, 2004) for named entity recognition, our approach used a finer-grained design including 11 different labels. As shown in Table 8 , such a design not only allowed us to recognize individual mutation components, but also led to higher accuracy in extracted results. Note that results in Table 8 do not involve the use of post-processing patterns (i.e. we show results directly derived from the CRF module). 
Evaluation of different features
In order to examine the contribution of individual feature types, we performed a feature ablation study where different types of features were removed from the entire set of features one at a time. As shown in Table 9 , the largest drop in performance was due to the removal of general linguistic features, followed by character and semantic features. On the other hand, the removal of case pattern or contextual features had little effect on final performance. Same as results in Table 8 above, no post-processing patterns were used in these experiments. 
Error analysis
Despite our best efforts, there are still errors in our mutation extraction results. We examined all the extraction errors from the test set and classified them into several major categories. As shown in Figure 4 , majority of our errors were due to boundary issues (shown in red) as we require exact string offset match in our evaluation. Further analysis shows that in many cases, our method only extracts partial mutation information such as "A>G" in "A>G polymorphism at position -670." This kind of errors affects both precision and recall. The second largest error category (shown in green) affects recall only, as our method simply missed true positive mutations like "p.S522fs 525stop." Our method was also confused by the some genotype descriptions (shown in blue) that have similar appearance to mutations by incorrectly predicting some genotypes (e.g. IVS9+459 GA+GG in PMID: 19880293) as mutations (false positive errors). Meanwhile, our specific genotypefiltering rule removes all mentions with identical wide type and mutant information during the post-processing, resulting in the loss of silent mutations (false negative errors). These three classes of errors accounted for over 80% of the errors made by our method. Other smaller error types (shown in gray) include identifying mentions that look like mutations (e.g. "Gly-X-Y") or the ones that are not included in the gold standard (e.g. we excluded natural language mutations). 
CONCLUSION
In summary, we introduced a CRF-based machine learning method for mutation extraction from text with high performance. Our method complements and extends existing methods in extracting a wide range of different types of sequence variants in scientific publications. There are several future directions for extending this work. First, tmVar is shown to be accurate on PubMed abstracts in this study. Although tmVar is also applicable to full text, future study is warranted to determine its actual performance on different text genres. Second, despite the fact this work in itself can be used and integrated by other research, just like any other standalone mutation extraction tools (e.g. MutationFinder), it is useful to extract and associate contextual information (e.g. gene/protein sequence) to the extracted mutations. Third, given our high extraction performance, we are interested in exploring direct applications of this work in the framework of computer-assisted biocuration (Lu and Hirschman, 2012; Névéol, et al., 2011; Névéol, et al., 2012; Wei, et al., 2012a) . Indeed, we have started discussing potential opportunities of contributing our computer-generated results to dbSNP (Lon Phan, personal communication) . Finally, together with our ability to recognize proteins and diseases (Doğan and Lu, 2012a; Lu, et al., 2011; Wei, et al., 2012c) , we would like to investigate automatic methods for characterizing de facto relationships between sequence variations in complex diseases buried in the biomedical literature.
